PHARMALAB ApS: Financial statements 2020
CVR: 33058101
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PHARMALAB ApS (CVR 33058101) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -10,265 and a net result of DKK -8,054 compared with DKK -22,849 the year before. Equity in the 2020 report amounted to DKK -35,498.
- Gross Profit
- DKK -10,265
- Profit/Loss
- DKK -8,054
- Equity
- DKK -35,498
- Total Assets
- DKK 17,118
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -10 t. | -8 t. | -35 t. | - |
| 2019 | - | -28 t. | -23 t. | -27 t. | - |
| 2018 | - | -138 t. | 286 t. | -5 t. | - |
| 2017 | - | 8 t. | -22 t. | -291 t. | 0 |
| 2016 | - | -198 t. | -216 t. | -269 t. | - |
Official annual report
How creditworthy is PHARMALAB ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PHARMALAB ApS has published its annual report for 2019. Gross profit came to DKK -28,250, and the net result was DKK -22,849.
About PHARMALAB ApS
PHARMALAB ApS was a Danish company of the type Anpartsselskab based in Hårlev, founded in 2010. The company has been dissolved on 18 March 2025. The company was registered under the industry Fremstilling af andre maskiner til generelle formål i.a.n.. According to the 2023 annual report, the company had an average of 1 employee. In 2023, the company reported a gross profit of DKK -42,256 and a net result of DKK -31,505 compared with DKK -16,738 the year before. Equity in the 2023 report amounted to DKK -107,589.